Trademark: 88899162
Status Date
Monday, June 6, 2022
Filing Date
Monday, May 4, 2020
Published for Opposition
Tuesday, September 7, 2021
Abandoned Date
Monday, June 6, 2022
44 Medical blood testing for diagnostic purposes to measure cell-mediated immunity to the SARS-CoV-2 virus
Jun 6, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 6, 2022
Abandonment - No Use Statement Filed
Nov 2, 2021
Noa E-Mailed - Sou Required From Applicant
Sep 7, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 7, 2021
Published For Opposition
Aug 18, 2021
Notification Of Notice Of Publication E-Mailed
Aug 4, 2021
Approved For Pub - Principal Register
Jul 22, 2021
Teas/Email Correspondence Entered
Jul 22, 2021
Correspondence Received In Law Office
Jul 22, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 21, 2021
Assigned To Lie
Jul 3, 2021
Notice Of Revival - E-Mailed
Jul 2, 2021
Teas Response To Office Action Received
Jul 2, 2021
Petition To Revive-Granted
Jul 2, 2021
Teas Petition To Revive Received
May 27, 2021
Teas Change Of Correspondence Received
May 27, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
May 27, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 20, 2021
Abandonment Notice E-Mailed - Failure To Respond
May 20, 2021
Abandonment - Failure To Respond Or Late Response
Nov 4, 2020
Notification Of Non-Final Action E-Mailed
Nov 4, 2020
Non-Final Action E-Mailed
Nov 4, 2020
Non-Final Action Written
Nov 2, 2020
Assigned To Examiner
May 15, 2020
New Application Office Supplied Data Entered
May 7, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
